Manufacturer
Sanofi Winthrop Industrie
Contents
Dupilumab
Indication
Moderate to severe atopic dermatitis in adult patients inadequately controlled w/ topical prescription therapies or when those therapies are not advisable, can be used w/ or w/o topical corticosteroids.
Instruction
Administer via Subcutaneous injection.
Drug interaction
Modulated formation of CYP450 enzymes. Live & non-live vaccines.